Target intelligence / Profile preview

Reactive oxygen species modulator 1 (ROMO1)

Target
ROMO1
Molecular classification
Mitochondrial protein, Non-selective ion channel (viroporin-like), Other
01

Overview

Reactive oxygen species modulator 1 (ROMO1) is a nuclear-encoded mitochondrial inner membrane protein with dual functions as a modulator of reactive oxygen species (ROS) production and as a viroporin-like non-selective ion channel. ROMO1 consists of 79 amino acids, integrates into the inner mitochondrial membrane, and forms homo-oligomeric channels involved in ion homeostasis. It plays a key role in mitochondrial dynamics, facilitating mitochondrial fusion and cristae formation. ROMO1-derived ROS are essential for cell cycle progression, cellular proliferation, and normal redox signaling, but excess activity leads to cellular stress, apoptosis, and is associated with various disease states including cancer, where it may contribute to tumor progression, recurrence, and therapy resistance. ROMO1 is evolutionarily conserved and serves as a potential therapeutic target and biomarker for cancer and other oxidative stress–related diseases.

Other names
C20orf52ROS modulator 1MTGMbA353C18.2MTGMPEpididymis tissue protein Li 175GlyrichinMitochondrial targeting GxxxG motif proteinProtein MGR2 homologPCM19Mitochondrial targeting GXXXG protein
02

Mechanism of action

Inhibition of non-selective cation channel activity (e.g., by HMA); Modulation of ROS-dependent signaling pathways.

03

Biological functions

Reactive oxygen species regulationMitochondrial dynamicsMitochondrial ion homeostasisCell proliferationCell cycle progressionApoptosisCell death
04

Disease associations

CancerInflammationOxidative stress–related disordersAgingChemoresistance
05

Safety considerations

Disruption of redox homeostasisInduction of cellular oxidative stress and potential apoptosisPotential for therapy resistance in cancer
06

Interacting drugs

Hexamethylene amiloride (HMA)

1 more in the full profile.

07

Biomarkers

ROMO1 expression as a biomarker for cancer progression and recurrence

Beyond the preview

Go deeper on Reactive oxygen species modulator 1 (ROMO1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reactive oxygen species modulator 1 (ROMO1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call